vs
Evolv Technologies Holdings, Inc.（EVLV）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Evolv Technologies Holdings, Inc.的2.0倍（$75.5M vs $38.5M），Evolv Technologies Holdings, Inc.同比增速更快（32.3% vs 27.7%），过去两年Evolv Technologies Holdings, Inc.的营收复合增速更高（31.8% vs 31.3%）
该企业总部位于美国旧金山，是一家人工智能科技公司，成立于2007年，成立后累计获得超1.43亿美元投资，2016年时曾是全球融资规模最高的人工智能企业，业务聚焦电子商务、线上内容与交易领域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EVLV vs PBYI — 直观对比
营收规模更大
PBYI
是对方的2.0倍
$38.5M
营收增速更快
EVLV
高出4.6%
27.7%
两年增速更快
EVLV
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.5M | $75.5M |
| 净利润 | $10.9M | — |
| 毛利率 | 48.4% | 69.3% |
| 营业利润率 | -20.7% | 22.7% |
| 净利率 | 28.3% | — |
| 营收同比 | 32.3% | 27.7% |
| 净利润同比 | 169.2% | — |
| 每股收益（稀释后） | $0.07 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVLVPBYI
| Q4 25 | $38.5M | $75.5M | ||
| Q3 25 | $42.9M | $54.5M | ||
| Q2 25 | $32.5M | $52.4M | ||
| Q1 25 | $32.0M | $46.0M | ||
| Q4 24 | $29.1M | $59.1M | ||
| Q3 24 | $27.4M | $80.5M | ||
| Q2 24 | $25.2M | $47.1M | ||
| Q1 24 | $22.2M | $43.8M |
净利润EVLVPBYI
| Q4 25 | $10.9M | — | ||
| Q3 25 | $-1.8M | $8.8M | ||
| Q2 25 | $-40.5M | $5.9M | ||
| Q1 25 | $-1.7M | $3.0M | ||
| Q4 24 | $-15.7M | — | ||
| Q3 24 | $-30.4M | $20.3M | ||
| Q2 24 | $3.4M | $-4.5M | ||
| Q1 24 | $-11.3M | $-4.8M |
毛利率EVLVPBYI
| Q4 25 | 48.4% | 69.3% | ||
| Q3 25 | 49.7% | 77.7% | ||
| Q2 25 | 49.8% | 76.5% | ||
| Q1 25 | 59.8% | 77.1% | ||
| Q4 24 | 57.5% | 76.4% | ||
| Q3 24 | 57.8% | 63.9% | ||
| Q2 24 | 58.5% | 77.4% | ||
| Q1 24 | 54.8% | 75.5% |
营业利润率EVLVPBYI
| Q4 25 | -20.7% | 22.7% | ||
| Q3 25 | -20.1% | 17.6% | ||
| Q2 25 | -53.8% | 12.7% | ||
| Q1 25 | -45.0% | 8.7% | ||
| Q4 24 | -64.9% | 22.6% | ||
| Q3 24 | -70.0% | 27.4% | ||
| Q2 24 | -88.7% | -4.6% | ||
| Q1 24 | -98.8% | -5.3% |
净利率EVLVPBYI
| Q4 25 | 28.3% | — | ||
| Q3 25 | -4.2% | 16.2% | ||
| Q2 25 | -124.6% | 11.2% | ||
| Q1 25 | -5.3% | 6.5% | ||
| Q4 24 | -54.0% | — | ||
| Q3 24 | -111.3% | 25.2% | ||
| Q2 24 | 13.6% | -9.6% | ||
| Q1 24 | -50.8% | -11.0% |
每股收益（稀释后）EVLVPBYI
| Q4 25 | $0.07 | $0.26 | ||
| Q3 25 | $-0.01 | $0.17 | ||
| Q2 25 | $-0.25 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $-0.10 | $0.40 | ||
| Q3 24 | $-0.19 | $0.41 | ||
| Q2 24 | $0.02 | $-0.09 | ||
| Q1 24 | $-0.07 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.1M | $97.5M |
| 总债务越低越好 | $28.6M | $22.7M |
| 股东权益账面价值 | $119.4M | $130.3M |
| 总资产 | $304.4M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.24× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EVLVPBYI
| Q4 25 | $49.1M | $97.5M | ||
| Q3 25 | $56.2M | $94.4M | ||
| Q2 25 | $36.9M | $96.0M | ||
| Q1 25 | $35.0M | $93.2M | ||
| Q4 24 | $51.9M | $101.0M | ||
| Q3 24 | $56.0M | $96.7M | ||
| Q2 24 | $56.5M | $96.8M | ||
| Q1 24 | $81.0M | $107.2M |
总债务EVLVPBYI
| Q4 25 | $28.6M | $22.7M | ||
| Q3 25 | $28.5M | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益EVLVPBYI
| Q4 25 | $119.4M | $130.3M | ||
| Q3 25 | $102.2M | $115.3M | ||
| Q2 25 | $92.7M | $104.7M | ||
| Q1 25 | $121.1M | $97.1M | ||
| Q4 24 | $117.7M | $92.1M | ||
| Q3 24 | $129.0M | $71.1M | ||
| Q2 24 | $151.2M | $48.5M | ||
| Q1 24 | $139.8M | $51.0M |
总资产EVLVPBYI
| Q4 25 | $304.4M | $216.3M | ||
| Q3 25 | $304.3M | $202.9M | ||
| Q2 25 | $280.4M | $194.9M | ||
| Q1 25 | $256.0M | $196.2M | ||
| Q4 24 | $268.1M | $213.3M | ||
| Q3 24 | $278.5M | $220.7M | ||
| Q2 24 | $269.1M | $205.0M | ||
| Q1 24 | $280.0M | $214.1M |
负债/权益比EVLVPBYI
| Q4 25 | 0.24× | 0.17× | ||
| Q3 25 | 0.28× | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流EVLVPBYI
| Q4 25 | $15.6M | $14.4M | ||
| Q3 25 | $3.5M | $9.7M | ||
| Q2 25 | $2.1M | $14.1M | ||
| Q1 25 | $-2.5M | $3.6M | ||
| Q4 24 | $3.2M | $15.6M | ||
| Q3 24 | $3.7M | $11.0M | ||
| Q2 24 | $-21.6M | $1.0M | ||
| Q1 24 | $-16.2M | $11.2M |
自由现金流EVLVPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率EVLVPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度EVLVPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率EVLVPBYI
| Q4 25 | 1.43× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -6.31× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
